NASDAQ:GOCO GoHealth (GOCO) Stock Price, News & Analysis $8.81 -0.63 (-6.67%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$8.81 0.00 (0.00%) As of 05/2/2025 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About GoHealth Stock (NASDAQ:GOCO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get GoHealth alerts:Sign Up Key Stats Today's Range$8.74▼$9.5050-Day Range$8.81▼$18.4152-Week Range$7.27▼$21.00Volume62,969 shsAverage Volume37,908 shsMarket Capitalization$202.71 millionP/E RatioN/ADividend YieldN/APrice Target$13.00Consensus RatingHold Company OverviewGoHealth, Inc. operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. It provides Medicare plans, including Medicare Advantage, Medicare Supplement and Prescription Drug, and Medicare Special Needs Plans. The company also offers partner marketing services. It sells its products through carriers and online platform, as well as independent and external agencies. The company was founded in 2001 and is headquartered in Chicago, Illinois.Read More… GoHealth Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks46th Percentile Overall ScoreGOCO MarketRank™: GoHealth scored higher than 46% of companies evaluated by MarketBeat, and ranked 586th out of 949 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingHold Consensus RatingGoHealth has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageGoHealth has received no research coverage in the past 90 days.Read more about GoHealth's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for GoHealth are expected to grow in the coming year, from ($5.50) to ($3.91) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of GoHealth is -2.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of GoHealth is -2.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioGoHealth has a P/B Ratio of 0.49. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about GoHealth's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.14% of the float of GoHealth has been sold short.Short Interest Ratio / Days to CoverGoHealth has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in GoHealth has recently decreased by 1.67%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGoHealth does not currently pay a dividend.Dividend GrowthGoHealth does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.14% of the float of GoHealth has been sold short.Short Interest Ratio / Days to CoverGoHealth has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in GoHealth has recently decreased by 1.67%, indicating that investor sentiment is improving. News and Social Media0.6 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 2 news articles for GoHealth this week, compared to 1 article on an average week.Search Interest1 people have searched for GOCO on MarketBeat in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, GoHealth insiders have not sold or bought any company stock.Percentage Held by Insiders35.01% of the stock of GoHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 24.21% of the stock of GoHealth is held by institutions.Read more about GoHealth's insider trading history. Receive GOCO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GoHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address GOCO Stock News HeadlinesGOCO INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into GoHealth, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the FirmMay 2 at 6:43 PM | globenewswire.comGoHealth Extends CEO Vijay Kotte’s Contract and CompensationApril 7, 2025 | tipranks.comTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new blockchain development…May 4, 2025 | Crypto 101 Media (Ad)RBC Capital Keeps Their Hold Rating on GoHealth (GOCO)March 11, 2025 | markets.businessinsider.comGoHealth, Inc.: GoHealth Reports Strong Fourth Quarter and Fiscal Year 2024 Results, Driven by a Successful Annual Enrollment PeriodFebruary 28, 2025 | finanznachrichten.deGoHealth (GOCO) Gets a Buy from Noble FinancialFebruary 28, 2025 | markets.businessinsider.comGoHealth Inc (GOCO) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Cost ...February 28, 2025 | finance.yahoo.comWilliam Blair Sticks to Their Buy Rating for GoHealth (GOCO)February 27, 2025 | markets.businessinsider.comSee More Headlines GOCO Stock Analysis - Frequently Asked Questions How have GOCO shares performed this year? GoHealth's stock was trading at $13.39 at the beginning of 2025. Since then, GOCO shares have decreased by 34.2% and is now trading at $8.81. View the best growth stocks for 2025 here. How were GoHealth's earnings last quarter? GoHealth, Inc. (NASDAQ:GOCO) announced its quarterly earnings data on Thursday, November, 7th. The company reported ($3.73) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($3.19) by $0.54. The firm had revenue of $118.29 million for the quarter, compared to the consensus estimate of $105.93 million. GoHealth had a negative net margin of 4.32% and a negative trailing twelve-month return on equity of 17.17%. Read the conference call transcript. When did GoHealth IPO? GoHealth (GOCO) raised $750 million in an initial public offering (IPO) on Wednesday, July 15th 2020. The company issued 39,500,000 shares at a price of $18.00-$20.00 per share. Goldman Sachs, BofA Securities and Morgan Stanley served as the underwriters for the IPO and Barclays, Credit Suisse, Evercore ISI, RBC Capital Markets, William Blair, Cantor, SunTrust Robinson Humphrey and Loop Capital Markets were co-managers. Who are GoHealth's major shareholders? Top institutional investors of GoHealth include FNY Investment Advisers LLC (0.01%). Insiders that own company stock include Cayman Gp Ltd Ccp III, Blizzard Holdings C LP Cb, Vijay Kotte and Jason Schulz. View institutional ownership trends. How do I buy shares of GoHealth? Shares of GOCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of GoHealth own? Based on aggregate information from My MarketBeat watchlists, some other companies that GoHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Invesco QQQ (QQQ), Tesla (TSLA), Netflix (NFLX) and Intel (INTC). Company Calendar Last Earnings11/07/2024Today5/03/2025Next Earnings (Estimated)5/08/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance Industry Insurance agents, brokers, & service Sub-IndustryInsurance Current SymbolNASDAQ:GOCO CIK1808220 Webwww.gohealth.com Phone312-386-8200FaxN/AEmployees5,450Year FoundedN/APrice Target and Rating Average Stock Price Target$13.00 High Stock Price Target$13.00 Low Stock Price Target$13.00 Potential Upside/Downside+47.6%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.72) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-63,260,000.00 Net Margins-4.32% Pretax Margin-9.81% Return on Equity-17.17% Return on Assets-4.58% Debt Debt-to-Equity Ratio1.72 Current Ratio1.18 Quick Ratio1.18 Sales & Book Value Annual Sales$798.89 million Price / Sales0.25 Cash Flow$1.44 per share Price / Cash Flow6.10 Book Value$18.06 per share Price / Book0.49Miscellaneous Outstanding Shares23,009,000Free Float14,887,000Market Cap$202.71 million OptionableNot Optionable Beta1.71 10 Stocks Set to Soar in Spring 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NASDAQ:GOCO) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GoHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GoHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.